7 Results

People

  1. Houghton
    Houghton
  2. Sadelain
    Sadelain
  3. Gregor
    Gregor
  4. Wolchok
    Wolchok
  5. Latouche
    Latouche
  6. Riviere
    Riviere
  7. Scher
    Scher
  8. Perales
    Perales
  9. Turaga
    Turaga
  10. Young
    Young

Groups

  1. Center for Hematologic Malignancies (7)
  2. Department of Medicine (7)
  3. GSK Faculty (7)
  4. Hematologic Malignancies Research (7)
  5. Hematologic Malignancies, Division of (7)
  6. Immunology Program Faculty (7)
  7. Molecular Pharmacology and Chemistry Program Faculty (7)
  8. Sloan Kettering Institute Faculty (7)
  9. Melanoma and Immunotherapeutics Service (5)
  10. Solid Tumor Oncology Division (5)
  1. "Center for Hematologic Malignancies"
  2. "Department of Medicine"
  3. "Hematologic Malignancies, Division of"
  4. "Sloan Kettering Institute Faculty"
  5. "Alan Houghton"
  6. "Michel Sadelain"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (1)
Groups
  1. Center for Hematologic Malignancies (7)
  2. Department of Medicine (7)
  3. GSK Faculty (7)
  4. Hematologic Malignancies Research (7)
  5. Hematologic Malignancies, Division of (7)
  6. Immunology Program Faculty (7)

More Groups

People
  1. Alan Houghton (7)
  2. Michel Sadelain (7)
  3. Jedd Wolchok (5)
  4. Polly Gregor (5)
  5. Jean-Baptiste Latouche (4)
  6. Howard Scher (3)

More People

Years
  1. 2006 (2)
  2. 2005 (1)
  3. 2004 (1)
  4. 2003 (1)
  5. 2001 (1)
  6. 2000 (1)
Publications
  1. Journal of Immunology (2)
  2. Vaccine (2)
  3. Clinical Cancer Research (1)
  4. International Journal of Cancer (1)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (1)
Publishers
  1. American Association for Cancer Research (2)
  2. Elsevier Inc. (2)
  3. The American Association of Immunologists, Inc (2)
  4. John Wiley & Sons (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner
    Journal Article

    Yuan, J.; Latouche, J. B.; Hodges, J.; Houghton, A. N.; Heller, G.; Sadelain, M.; Riviere, I.; Young, J. W.
    Journal of Immunology (2006)

    Fulltext@MSK | Save
  • Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center
    Journal Article

    Bergman, P. J.; Camps-Palau, M. A.; McKnight, J. A.; Leibman, N. F.; Craft, D. M.; Leung, C.; Liao, J.; Riviere, I.; Sadelain, M.; Hohenhaus, A. E.; more...
    Vaccine (2006)

    Fulltext@MSK | Save
  • Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination
    Journal Article

    Gregor, P. D.; Wolchok, J. D.; Turaga, V.; Latouche, J. B.; Sadelain, M.; Bacich, D.; Heston, W. D. W.; Houghton, A. N.; Scher, H. I.
    International Journal of Cancer (2005)

    Fulltext@MSK | Save
  • CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems
    Journal Article

    Gregor, P. D.; Wolchok, J. D.; Ferrone, C. R.; Buchinsky, H.; Guevara-Patiño, J. A.; Perales, M. A.; Mortazavi, F.; Bacich, D.; Heston, W.; Latouche, J. B.; more...
    Vaccine (2004)

    Fulltext@MSK | Save
  • Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: A phase I trial
    Journal Article

    Bergman, P. J.; McKnight, J.; Novosad, A.; Charney, S.; Farrelly, J.; Craft, D.; Wulderk, M.; Jeffers, Y.; Sadelain, M.; Hohenhaus, A. E.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • A mouse model for prostate specific membrane antigen DNA vaccine development: PSMA DNA vaccines result in autoantibodies and reduced tumor growth
    Meeting Abstract

    Gregor, P. D.; Wolchok, J. D.; Turaga, V.; Latouche, J. B.; Sadelain, M.; Houghton, A.; Scher, H. I.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save
  • Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: Implications for the clinical use of dendritic cells
    Journal Article

    Schnell, S.; Young, J. W.; Houghton, A. N.; Sadelain, M.
    Journal of Immunology (2000)

    Fulltext@MSK | Save